Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein IV Catheter In a Pediatric Population

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged newborn to 12 years~* Has written or verbal order for insertion of an IV~* Requires peripheral IV therapy (catheter)~* Has an insertion site in the hand, forearm, foot, leg, or head free of deformities, phlebitis, infiltration, dermatitis, burns, lesions or tattoos~* Demonstrates cooperation with a catheter insertion and the study protocol~Exclusion Criteria:~* In the newborn nursery or intensive care units (neonatal or pediatric)~* On patient-controlled analgesia pump~* Patient is anesthetized~* Terminally ill~* Transferred from the operating room less than 8 hours postanasthesia~* Any child the research staff deem unobservable~* The study IV catheter site will be placed below an old infusion site~* The study IV site needs to be immobilized with a splint or other devices~* Has or has had a previous IV catheter related phlebitis or infiltration during current hospitalization~* Will require a power injection for a radiologic procedure during participation in this study

- Gender: ALL
- Minimum Age: None
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Treatment with OptiVein (Type: EXPERIMENTAL): The patient will have an IV catheter placed with the use of OptiVein device.
- Treatment with Vasofix Certo (Type: ACTIVE_COMPARATOR): The patient will have an IV catheter placed with the use of Vasofix Certo device.

Based on this trial design, predict the completion outcome and termination type (if applicable).